The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQRT.L Regulatory News (QRT)

  • There is currently no data for QRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR Grant of Share Options

15 May 2017 07:38

RNS Number : 0999F
Quarto Group Inc
15 May 2017
 

The Quarto Group, Inc

("the Company")

PDMR Grant of Share Options

 

The Quarto Group (LSE: QRT), the leading global illustrated book publisher, announces that on 5 May 2017 it has granted 137,306 options under the Company's existing Performance Share Plan to Persons Discharging Managerial Responsibility ("PDMRs") as listed below. The awards have a vesting date of 28 April 2021.

 

PDMR

Position

Number of Options granted

David Breuer

Chief Creative Officer

16,635

Anne Crompton

Group Director of Legal & Business Affairs

10,932

Ken Fund

Chief Operating Officer

25,496

Marcus Leaver

Chief Executive officer

70,935

Karine Marko

Group Director of Foreign Rights

13,308

Dorothee de Montgolfier

Group Director of Communications

7,605

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

 

1

Details of the persons discharging managerial responsibilities / person closely associated

a)

Name

1. David Breuer

2. Anne Crompton

3. Ken Fund

4. Marcus Leaver

5. Karine Marko

6. Dorothee de Montgolfier

2

Reason for the notification

a)

Position/status

Classified as PDMRs of the Company

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

The Quarto Group Inc

b)

LEI

[N/A]

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Common stock of US$0.10 each in the capital of the Company ("Common Stock")

Identification code

US74772E1001

b)

Nature of the transaction

Grant of options over Common Stock

c)

Price(s) and volume(s)

Exercise Prices per share

Volumes

 

1. Nil Cost Options

2. Nil Cost Options

3. Nil Cost Options

4. Nil Cost Options

5. Nil Cost Options

6. Nil Cost Options

1. 16,635

2. 10,932

3. 25,496

4. 70,935

5. 13,308

6. 7,605

d)

Aggregated information

- Aggregated volume

- Price

Aggregated volume: 137,306

Price: Nil cost options

e)

Date of the transaction

5 May 2017

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

For further information, please contact:

 

The Quarto Group

Marcus Leaver, CEO

Dorothée de Montgolfier, Group Director of Communications

020 7700 9002

 

Bell Pottinger

Elly Williamson

020 3772 2573

About The Quarto Group

The Quarto Group (LSE: QRT) is the leading global illustrated book publishing group. Our mission is to make and sell great books that entertain, educate and enrich the lives of adults and children around the world.

Quarto creates and owns proprietary content, publishing books from a diverse portfolio of imprints that are creatively independent and expert in developing long-lasting content across specific niches of interest.

Quarto sells books across 50 countries and in 39 languages through a variety of traditional and non-traditional channels, while constantly looking for new ways to create and deliver content that people need.

Quarto employs over 400 talented people in the US, UK and Hong Kong. The group was founded in London in 1976. It is domiciled in the US and listed on the London Stock Exchange. 

For more information, visit quarto.com or follow us on Twitter at @TheQuartoGroup.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSFWSMIFWSEDI
Date   Source Headline
14th Dec 20232:16 pmRNSResult of Special Meeting
30th Nov 202310:28 amRNSCirc re Proposed Cancellation: Admission of Shares
30th Aug 202310:00 amRNSHalf-year Results
28th Jun 20235:03 pmRNSDirector/PDMR Shareholding
6th Jun 202311:41 amRNSPCA Shareholding
24th May 20231:18 pmRNSAnnual Meeting Result
26th Apr 20235:40 pmRNSAnnual Report and Notice of Annual Meeting
31st Mar 202310:11 amRNSFinal Results
18th Oct 20229:21 amRNSDirector Declaration
30th Aug 202210:00 amRNSHalf-year Report
26th Jul 202210:58 amRNSPCA Shareholding
8th Jul 20223:14 pmRNSChange of auditor
6th Jul 20221:50 pmRNSPCA Shareholding
13th Jun 20222:25 pmRNSPCA Shareholding
27th May 20223:19 pmRNSDirector appointment
24th May 20221:00 pmRNSAnnual Meeting Result
5th May 20221:00 pmRNSPCA Shareholding
29th Apr 20222:23 pmRNSHolding(s) in Company
28th Apr 20221:44 pmRNSPCA Shareholding
26th Apr 20227:00 amRNSPCA Shareholding
22nd Apr 20228:21 amRNSPCA Shareholding
19th Apr 20223:07 pmRNSPCA Shareholding
14th Apr 20222:44 pmRNSPCA Shareholding
12th Apr 20223:20 pmRNSPCA Shareholding
12th Apr 202211:32 amRNSAnnual Report and Notice of Annual Meeting
8th Apr 20223:53 pmRNSPCA Shareholding
6th Apr 20223:22 pmRNSPCA Shareholding
4th Apr 20223:51 pmRNSPCA Shareholding
17th Mar 20229:11 amRNSFinal Results
27th Jan 202211:45 amRNSPCA Shareholding
26th Jan 20222:42 pmRNSPCA Shareholding
10th Jan 20221:09 pmRNSPCA Shareholding
7th Jan 20223:52 pmRNSPCA Shareholding
29th Nov 20219:27 amRNSDirector Change (update)
17th Nov 202111:52 amRNSGroup Chief Executive Officer Appointment
11th Oct 20212:56 pmRNSDirector/PDMR Shareholding
17th Aug 202112:24 pmRNSPCA/PDMR Shareholding
16th Aug 20213:08 pmRNSPCA/PDMR Shareholding
10th Aug 20212:52 pmRNSPCA shareholding
3rd Aug 20211:27 pmRNSHalf-year Report
1st Jul 20214:58 pmRNSDirectorate Change
3rd Jun 20214:00 pmRNSDirector Change
25th May 20211:33 pmRNSResult of Annual Meeting
22nd Apr 20217:34 amRNSAnnual Report and Notice of Annual Meeting
22nd Mar 20217:00 amRNSFinal Results
5th Mar 20217:00 amRNSAmalgamation of Stock Lines & Total Voting Rights
17th Feb 20217:00 amRNSAnnouncing new bank facility
13th Oct 20204:09 pmRNSDirector/PDMR Shareholding
18th Sep 20207:00 amRNSBoard Changes
10th Sep 202010:55 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.